{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:59:39Z","timestamp":1773694779725,"version":"3.50.1"},"reference-count":13,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003360","name":"Ligue Genevoise Contre le Cancer","doi-asserted-by":"publisher","award":["1409"],"award-info":[{"award-number":["1409"]}],"id":[{"id":"10.13039\/501100003360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Malignant pleural mesothelioma (MPM) is a thoracic aggressive cancer caused by asbestos exposure, which is difficult to diagnose and treat. Here, we characterized an in vivo orthotopic xenograft model consisting of human mesothelioma cells (designed as H2052\/484) derived from a pleural NCI-H2052 tumor injected in partially immunodeficient athymic mice. We assessed tumor formation and tumor-dependent patterns of inflammation. H2052\/484 cells conserved their mesothelioma phenotype and most characteristics from the parental NCI-H2052 cells. After intra-thoracic injection of H2052\/484 cells, thoracic tumors developed in nearly all mice (86%) within 14 days, faster than from parental NCI-H2052 cells. When the mice were euthanized, the pleural lavage fluid was examined for immune cell profiles. The pleural immune cell population increased with tumor development. Interestingly, the proportion of myeloid-derived suppressor cell and macrophage (especially CD206+ M2 macrophages) populations increased in the pleural fluid of mice with large mesothelioma development, as previously observed in immunocompetent mice. This reliable orthotopic model recapitulates human mesothelioma and may be used for the study of new treatment strategies.<\/jats:p>","DOI":"10.3390\/ijms19071881","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T10:40:50Z","timestamp":1530009650000},"page":"1881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Experimental Model of Human Malignant Mesothelioma in Athymic Mice"],"prefix":"10.3390","volume":"19","author":[{"given":"Didier J.","family":"Colin","sequence":"first","affiliation":[{"name":"MicroPET\/SPECT\/CT Imaging Laboratory, Centre for BioMedical Imaging (CIBM), University Hospitals and University of Geneva, 1211 Geneva 4, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cottet-Dumoulin","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Endocrine Surgery, University Hospitals and University of Geneva, 1211 Geneva 4, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Faivre","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Endocrine Surgery, University Hospitals and University of Geneva, 1211 Geneva 4, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Germain","sequence":"additional","affiliation":[{"name":"MicroPET\/SPECT\/CT Imaging Laboratory, Centre for BioMedical Imaging (CIBM), University Hospitals and University of Geneva, 1211 Geneva 4, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-496X","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Triponez","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Endocrine Surgery, University Hospitals and University of Geneva, 1211 Geneva 4, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Serre-Beinier","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Endocrine Surgery, University Hospitals and University of Geneva, 1211 Geneva 4, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2471\/BLT.14.142307","article-title":"The asbestos paradox: Global gaps in the translational science of disease prevention","volume":"93","author":"Ogunseitan","year":"2015","journal-title":"Bull. World Health Organ."},{"key":"ref_2","first-page":"S238","article-title":"Management of malignant pleural mesothelioma-The European experience","volume":"6","author":"Opitz","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11512","DOI":"10.18632\/oncotarget.7314","article-title":"Role of MIF\/CD74 signaling pathway in the development of pleural mesothelioma","volume":"7","author":"Cipriano","year":"2016","journal-title":"Oncotarget"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14728222.2011.550879","article-title":"CD74: An emerging opportunity as a therapeutic target in cancer and autoimmune disease","volume":"15","author":"Borghese","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1874226200902010079","article-title":"Immunodeficient mouse models: An overview","volume":"2","author":"Belizario","year":"2009","journal-title":"Open Immunol. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1173299","DOI":"10.1080\/2162402X.2016.1173299","article-title":"Murine mesothelioma induces locally-proliferating IL-10+TNF-\u03b1+CD206\u2212CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy","volume":"5","author":"Jackaman","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrd.2015.13","article-title":"Epithelial-mesenchymal transition: A new target in anticancer drug discovery","volume":"15","author":"Marcucci","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/217370a0","article-title":"Absence of thymus in a mouse mutant","volume":"217","author":"Pantelouris","year":"1968","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: Balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.4049\/jimmunol.1201161","article-title":"Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment","volume":"189","author":"Simpson","year":"2012","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.1201650","article-title":"Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor","volume":"190","author":"Yaddanapudi","year":"2013","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00418-004-0701-1","article-title":"Establishment of permanent cell lines purified from human mesothelioma: Morphological aspects, new marker expression and karyotypic analysis","volume":"122","author":"Philippeaux","year":"2004","journal-title":"Histochem. Cell Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/7\/1881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:10:16Z","timestamp":1760195416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/7\/1881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":13,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7]]}},"alternative-id":["ijms19071881"],"URL":"https:\/\/doi.org\/10.3390\/ijms19071881","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]}}}